Suppr超能文献

S-亚硝基化蛋白二硫键异构酶有助于肌萎缩侧索硬化症中突变型 SOD1 聚集。

S-nitrosylated protein disulfide isomerase contributes to mutant SOD1 aggregates in amyotrophic lateral sclerosis.

机构信息

Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

J Neurochem. 2013 Jan;124(1):45-58. doi: 10.1111/jnc.12046. Epub 2012 Nov 1.

Abstract

A major hallmark of mutant superoxide dismutase (SOD1)-linked familial amyotrophic lateral sclerosis is SOD1-immunopositive inclusions found within motor neurons. The mechanism by which SOD1 becomes aggregated, however, remains unclear. In this study, we aimed to investigate the role of nitrosative stress and S-nitrosylation of protein disulfide isomerase (PDI) in the formation of SOD1 aggregates. Our data show that with disease progression inducible nitric oxide synthase (iNOS) was up-regulated, which generated high levels of nitric oxide (NO) and subsequently induced S-nitrosylation of PDI in the spinal cord of mutant SOD1 transgenic mice. This was further confirmed by in vitro observation that treating SH-SY5Y cells with NO donor S-nitrosocysteine triggered a dose-dependent formation of S-nitrosylated PDI. When mutant SOD1 was over-expressed in SH-SY5Y cells, the iNOS expression was up-regulated, and NO generation was consequently increased. Furthermore, both S-nitrosylation of PDI and the formation of mutant SOD1 aggregates were detected in the cells expressing mutant SOD1(G93A). Blocking NO generation with the NOS inhibitor N-nitro-L-arginine attenuated the S-nitrosylation of PDI and inhibited the formation of mutant SOD1 aggregates. We conclude that NO-mediated S-nitrosylation of PDI is a contributing factor to the accumulation of mutant SOD1 aggregates in amyotrophic lateral sclerosis.

摘要

突变型超氧化物歧化酶(SOD1)相关性家族性肌萎缩侧索硬化症的一个主要标志是运动神经元内发现 SOD1 免疫阳性包涵体。然而,SOD1 聚集的机制仍不清楚。在本研究中,我们旨在研究硝化应激和蛋白二硫键异构酶(PDI)的 S-亚硝基化在 SOD1 聚集形成中的作用。我们的数据表明,随着疾病的进展,诱导型一氧化氮合酶(iNOS)上调,产生高水平的一氧化氮(NO),随后诱导突变型 SOD1 转基因小鼠脊髓中 PDI 的 S-亚硝基化。这在体外观察中得到进一步证实,即用 NO 供体 S-亚硝基半胱氨酸处理 SH-SY5Y 细胞会引发 S-亚硝基化 PDI 的剂量依赖性形成。当 SH-SY5Y 细胞中过表达突变型 SOD1 时,iNOS 表达上调,NO 的产生随之增加。此外,在表达突变型 SOD1(G93A)的细胞中均检测到 PDI 的 S-亚硝基化和突变型 SOD1 聚集体的形成。用 NOS 抑制剂 N-硝基-L-精氨酸阻断 NO 的产生可减弱 PDI 的 S-亚硝基化,并抑制突变型 SOD1 聚集体的形成。我们的结论是,NO 介导的 PDI 的 S-亚硝基化是导致肌萎缩侧索硬化症中突变型 SOD1 聚集体积累的一个因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验